Sulfone substituted imidazo ring ethers
    3.
    发明授权
    Sulfone substituted imidazo ring ethers 失效
    砜取代的咪唑环醚

    公开(公告)号:US07939526B2

    公开(公告)日:2011-05-10

    申请号:US10596117

    申请日:2004-12-03

    IPC分类号: A61K31/04 C07D215/38

    CPC分类号: C07D471/04 C07D471/14

    摘要: Imidazo ring compounds (e.g., imidazoquinolines, 6,7,8,9-tetrahydroimidazoquinolines, imidazonaphthyridines, and 6,7,8,9-tetrahydroimidazonaphthyridines) with a sulfide-, sulfinyl-, or sulfonyl-containing ether substituent at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

    摘要翻译: 咪唑环化合物(例如,咪唑并喹啉,6,7,8,9-四氢咪唑并喹啉,咪唑并吡啶和6,7,8,9-四氢咪唑并萘啶)与1-位硫醚基,亚磺酰基或磺酰基醚取代基 公开了含有化合物的药物组合物,中间体,制备该化合物的方法,以及这些化合物作为免疫调节剂的用途,用于诱导动物中的细胞因子生物合成和治疗包括病毒和肿瘤疾病在内的疾病。